Genomics companies in agreement with Rhone-Poulenc Rorer:
This article was originally published in Clinica
Executive Summary
Molecular Dynamics and Amersham Pharmacia Biotec are to supply drug company Rhone-Poulenc Rorer with microarray technology for measuring gene expression under an agreement between the three companies. Rhone-Poulenc will gain early access to integrated microarray systems in exchange for funding and technical expertise. The comparison of gene expression between normal and diseased genes is expected to improve the development of new diagnostics and therapeutics.